Objective Clozapine is the most effective antipsychotic for treatment refractory people with
schizophrenia, yet many patients only partially respond. Accumulating preclinical and clinical …

The focus of this report is to compare the psychiatric symptomatology of individuals with
schizophrenia who have died by suicide to those who have died by other means of death. This …

Background: Approximately one-third of people with schizophrenia have elevated levels of
antigliadin antibodies of the immunoglobulin G type (AGA IgG) — a higher rate than seen in …

Purpose/Background: Prolactin-related adverse effects contribute to nonadherence and
adverse health consequences, particularly in women with severe mental illness. Treating these …

Objective: This study compared rates of cervical cancer screening and acute care (primary
or gynecological) visits among women with and without a diagnosis of psychosis, substance …

… 3 , Stephanie M Feldman … 2 , James M Gold …

People with schizophrenia are 3–4 times more likely to die from cardiovascular disease
than the general population. Clozapine (CLZ) is the gold standard of treatment for refractory …

People with schizophrenia who have current substance use disorder (SUD) are generally
excluded from clinical trials for the following reasons: safety/side effect risk, concern about …

Kelly designed the study and oversaw research procedures. Sullivan worked with all research
participants and oversaw data collection. Koola and Kelly wrote the manuscript. Kelly, Earl…

This volume assembles more than 30 articles focusing on the visual, material, and environmental
arts of the Ancient Near East. Specific case studies range temporally from the fourth …